{"database": "lobbying", "table": "lobbying_activities", "rows": [[1696124, "de6c62bd-33f2-41a4-afde-9b83e8e7a48c", "Q2", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2015, "second_quarter", "MED", "H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)\nS. 320, The Medical Innovation Act.  Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2015-07-15T12:15:07.257000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1696124"], "units": {}, "query_ms": 35.06795596331358, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}